Sex differences in opioid analgesia: "From mouse to man"

Clinical Journal of Pain

Volumn 19, Issue 3, 2003, Pages 175-186

  Craft, Rebecca M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Gender; Morphine; Pain; Women

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ALFENTANIL; ASIMADOLINE; BREMAZOCINE; BUPRENORPHINE; BUTORPHANOL; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; DEZOCINE; ENADOLINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETHYLKETAZOCINE; ETORPHINE; FENTANYL; HORMONE RECEPTOR; HYDROMORPHONE; KAPPA OPIATE RECEPTOR AGONIST; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; LEVORPHANOL; MORPHINE; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALBUPHINE; NALORPHINE; NARCOTIC ANALGESIC AGENT; PENTAZOCINE; PETHIDINE; SEX HORMONE;

ANALGESIA; CHRONIC PAIN; DRUG EFFICACY; DRUG MECHANISM; DRUG SENSITIVITY; DRUG TOLERANCE; FEMALE; GENE MAPPING; HOT PLATE TEST; HUMAN; INFLAMMATION; MALE; MONKEY; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; REVIEW; SEX DIFFERENCE; SPECIES DIFFERENCE; TAIL FLICK TEST; TIME SERIES ANALYSIS;

ANALGESICS, OPIOID; ANIMALS; FEMALE; HUMANS; MALE; MICE; PAIN; PAIN MEASUREMENT; RESEARCH DESIGN; SEX CHARACTERISTICS; SEX FACTORS;

EID: 0038662987     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200305000-00005     Document Type: Review

References (106)

1. Bem SL. The measurement of psychological androgyny. J Consult Clin Psych. 1974;42:155-162.
2. Bem SL. Bem Sex Role Inventory: Professional Manual. Palo Alto, CA: Consulting Psychologists Press; 1981.
3. Robinson ME, Riley JL, Myers CD, et al. Gender role expectations of pain: relationship to sex differences in pain. J Pain. 2001;2:251-257.
4. Thornton SR, Wang AF, Smith FL. Characterization of neonatal rat morphine tolerance and dependence. Eur J Pharmacol. 1997;340:161-167.
5. Kasson BG, George R. Endocrine influences on the actions of morphine: IV. Effects of sex and strain. Life Sci. 1984;34:1627-1634.
6. Kinsley CH, Mann PE, Bridges RS. Prenatal stress alters morphine- and stress-induced analgesia in male and female rats. Pharmacol Biochem Behav. 1988;30:123-128.
7. Kanarek RB, Homoleski B. Modulation of morphine-induced antinociception by palatable solutions in male and female rats. Pharmacol Biochem Behav. 2000;66:653-659.
8. Craft RM, Stratmann JA, Bartok RE, et al. Sex differences in development of morphine tolerance and dependence in the rat. Psychopharmacology. 1999;143:1-7.
9. Cook CD, Barrett AC, Roach EL, et al. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the μ opioid receptor. Psychopharmacology. 2000;150:430-442.
10. Cicero TJ, Nock B, Meyer ER. Gender-related differences in the antinociceptive properties of morphine. J Pharmacol Exp Ther. 1996;279:767-773.
11. Baamonde AI, Hidalgo A, Andres-Trelles F. Sex-related differences in the effects of morphine and stress on visceral pain. Neuropharmacology. 1989;28:967-970.
12. Mogil JS, Chesler EJ, Wilson SG, et al. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci Biobehav Rev. 2000;24:375-389.
13. Baker L, Ratka A. Sex-specific differences in levels of morphine, morphine-3-glucuronide, and morphine analgesia in rats. Pain. 2002;95:65-74.
14. Barrett AC, Picker MJ. Presented at the 63rd Annual Meeting of the College on Drug Dependence, Scottsdale, AZ, June 16-21, 2001 (abstract).
15. Kepler KL, Kest B, Kiefel JM, et al. Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacol Biochem Behav. 1989;34:119-127.
16. Krzanowska EK, Bodnar RJ. Morphine antinociception elicited from the ventrolateral periaqueductal gray is sensitive to sex and gonadectomy differences in rats. Brain Res. 1999;821:224-230.
17. Boyer JS, Morgan MM, Craft RM. Microinjection of morphine into the rostral ventromedial medulla produces greater antinociception in male compared with female rats. Brain Res. 1998;796:315-318.
18. Kavaliers M, Innes DGL. Sex and day-night differences in opiate-induced responses of insular wild deer mice, Peromyscus maniculatus triangularis. Pharmacol Biochem Behav. 1987;27:477-482.
19. Candido J, Lutfy K, Billings B, et al. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation. Pharmacol Biochem Behav. 1992;42:685-692.
20. Kest B, Wilson SG, Mogil JS. Sex differences in supraspinal morphine analgesia are dependent on genotype. J Pharmacol Exp Ther. 1999;289:1370-1375.
21. Kest B, Palmese C, Hopkins E. A comparison of morphine analgesic tolerance in male and female mice. Brain Res. 2000;879:17-22.
22. B agonist baclofen. Neuroscience. 1995;69:345-349.
23. Zacny JP. Gender differences in opioid analgesia in human volunteers: cold pressor and mechanical pain. NIDA Res Monogr. 2002;182:22-23 (abstract).
24. Sarton E, Olofsen E, Romberg R, et al. Sex differences in morphine analgesia. Anesthesiology. 2000;93:1245-1254.
25. Sherman B, Barbier R, Crain S, et al. Very low dose naltrexone and gender modify morphine analgesia in patients with postoperative pain. Presented at the 19th Annual Meeting of the American Pain Society, Atlanta, GA, November 2-5, 2000 (abstract).
26. Cicero TJ, Nock B, Meyer ER. Sex-related differences in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations. J Pharmacol Exp Ther. 1997;282:939-944.
27. Bartok RE, Craft RM. Sex differences in opioid antinociception. J Pharmacol Exp Ther. 1997;282:769-778.
28. Craft RM, Tseng A, McNiel D, et al. Receptor-selective antagonism of opioid antinociception in male vs. female rats. Behav Pharmacol. 2001;12:591-602.
29. Craft RM, Bernal SA. Sex differences in opioid antinociception: kappa and mixed action agonists. Drug Alcohol Depend. 2001;63:215-228.
30. Patrick CA, Ko MCH, Woods JH. Comparison of antinociceptive effects induced by kappa opioid agonists in male and female mice. Analgesia. 1999;4:397-404.
31. Gear RW, Miaskowski C, Gordon NC, et al. Kappa-opioids produce significantly greater analgesia in women than in men. Nature Med. 1996;2:1248-1250.
32. Kepler KL, Standifer KM, Paul D, et al. Gender effects and central opioid analgesia. Pain. 1991;45:87-94.
33. Tershner SA, Mitchell JM, Fields HL. Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function. Pain. 2000;85:153-159.
34. Thornton SR, Smith FL. Characterization of neonatal rat fentanyl tolerance and dependence. J Pharmacol Exp Ther. 1997;281:514-521.
35. Negus SS, Zuzga DS, Mello NK. Sex differences in opioid antinociception in rhesus monkeys: antagonism of fentanyl and U50,488 by quadazocine. J Pain. 2002;3:218-226.
36. Gear RW, Miaskowski C, Gordon NC, et al. The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain. 1999;83:339-345.
37. Gear RW, Miaskowski C, Gordon NC, et al. Action of naloxone on gender-dependent analgesic and antianalgesic effects of nalbuphine in humans. J Pain. 2000;1:122-127.
38. Gear RW, Gordon NC, Heller PH, et al. Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett. 1996;205:207-209.
39. Binder W, Carmody J, Walker J. Effect of gender on anti-inflammatory and analgesic actions of two κ-opioids. J Pharmacol Exp Ther. 2000;292:303-309.
40. Barrett AC, Cook CD, Terner JM, et al. Sex and rat strain determine sensitivity to κ opioid-induced antinociception. Psychopharmacology. 2002;160:170-181.
41. van Haaren F, Scott S, Tucker LB. κ-Opioid receptor-mediated analgesia: hotplate temperature and sex differences. Eur J Pharmacol. 2000;408:153-159.
42. Kavaliers M, Choleris E. Sex differences in N-methyl-D-aspartate involvement in κ opioid and non-opioid predator-induced analgesia in mice. Brain Res. 1997;768:30-36.
43. Walker EA, Butelman ER, DeCosta BR, et al. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. J Pharmacol Exp Ther. 1993;267:280-286.
44. Gerak LR, Butelman ER, Woods JH, et al. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. J Pharmacol Exp Ther. 1994;271:993-999.
45. Butelman ER, Winger G, Zernig G, et al. Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys. J Pharmacol Exp Ther. 1995;272:845-853.
46. Zacny JP, Lichtor JL, Thapar P, et al. Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J Pharmacol Exp Ther. 1994;270:579-588.
47. Zacny JP, Conley K, Marks S. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers. J Pharmacol Exp Ther. 1997;280:1159-1169.
48. Zacny JP, Hill JL, Black ML, et al. Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers. J Pharmacol Exp Ther. 1998;286:1197-1207.
49. Vivian JA, DeYoung MB, Sumpter TL, et al. δ-Opioid receptor effects of butorphanol in rhesus monkeys. J Pharmacol Exp Ther. 1999;290:259-265.
50. Walker DJ, Zacy JP, Galva KE, et al. Subjective, psychomotor, and physiological effects of cumulative doses of mixed-action opioid in healthy volunteers. Psychopharmacology. 2001;155:362-371.
51. Walsh SL, Strain EC, Abreu ME, et al. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology. 2001;157:151-162.
52. Negus SS, Mello NK. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effect of estradiol replacement. J Pharmacol Exp Ther. 1999;290:1132-1140.
53. Picker MJ, Yarbrough J, Hughes CE, et al. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences. J Pharmacol Exp Ther. 1993;266:756-767.
54. Morgan D, Picker MJ. Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: importance of the drug's relative intrinsic efficacy at the mu receptor. Behav Pharmacol. 1996;7:261-284.
55. Fillingim RB, ed. Sex, Gender and Pain. Seattle: IASP Press; 2000.
56. Fillingim RB, Ness TJ. Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev. 2000;24:485-501.
57. Banerjee P, Chatterjee T, Ghosh J. Ovarian steroids and modulation of morphine-induced analgesia and catalepsy in female rats. Eur J Pharmacol. 1983;96:291-294.
58. Berglund LA, Simpkins JW. Alterations in brain opiate receptor mechanisms on proestrous aftemoon. Neuroendocrinology. 1988;48:394-400.
59. Stoffel EC, Ulibarri CM, Craft RM. Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats. Pain. (In press).
60. Negus SS, Mello NK. Effects of gonadal steroid hormone treatment on opioid antinociception in ovariectomized rhesus monkeys. Psychopharmacology. 2002;159:275-283.
61. Ryan SM, Maier SF. The estrous cycle and estrogen modulate stress-induced analgesia. Behav Neurosci. 1988;102:371-380.
62. Mogil JS. The genetic mediation of individual differences in sensitivity to pain and its inhibition. PNAS. 1999;96:7744-7751.
63. Mogil JS, Yu L, Basbaum AI. Pain genes: natural variation and transgenic mutants. Annu Rev Neurosci. 2000;23:777-811.
64. Bergeson SE, Helms ML, O'Toole LA, et al. Quantitative trait loci influencing morphine antinociception in four mapping populations. Mamm Genome. 2001;12:546-553.
65. Craft RM, Kalivas PW, Stratmann JA. Sex differences in discriminative stimulus effects of morphine in the rat. Behav Pharmacol. 1996;7:764-778.
66. Ratka A. Effects of estradiol and testosterone on pharmacodynamics and pharmacokinetics of morphine in male rats. J Idaho Acad Sci. 1995;31:11-24.
67. South SM, Wright AWE, Lau M, et al. Sex-related differences in antinociception and tolerance development following chronic intravenous infusion of morphine in the rat: modulatory role of testosterone via morphine clearance. J Pharmacol Exp Ther. 2001;297:446-457.
68. Smith MT, Watt JA, Cramond T. Morphine-3-glucuronide: a potent antagonist of morphine analgesia. Life Sci. 1990;47:579-585.
69. Ostrowski NL, Hill JM, Pert CB, et al. Autoradiographic visualization of sex differences in the pattern and density of opiate receptors in hamster hypothalamus. Brain Res. 1987;421:1-13.
70. Simerly RB, McCall LD, Watson SJ. Distribution of opioid peptides in the preoptic region: immunohistochemical evidence for a steroid-sensitive enkephalin sexual dimorphism. J Comp Neurol. 1988;276:442-459.
71. Hammer RP. μ-Opiate receptor binding in the medial preoptic area is cyclical and sexually dimorphic. Brain Res. 1990;515:187-192.
72. Weiland NG, Wise PM. Estrogen and progesterone regulate opiate receptor densities in multiple brain regions. Endocrinology. 1990;126:804-808.
73. Maggi R, Limonta P, Dondi D, Piva F. Modulation of the binding characteristics of hypothalamic mu opioid receptors in rats by gonadal steroids. J Steroid Biochem Molec Biol. 1991;40:113-121.
74. Lagrange AH, Rønnekleiv OK, Kelly MJ. Modulation of G protein-coupled receptors by an estrogen receptor that activates protein kinase A. J Pharmacol Exp Ther. 1997;51:605-612.
75. Carter A, Soliman MR. Estradiol and progesterone alter ethanol-induced effects on μ-opioid receptors in specific brain regions of ovariectomized rats. Life Sci. 1998;62:93-101.
76. Eckersell CB, Popper P, Micevych PE. Estrogen-induced alteration of μ-opioid receptor immunoreactivity in the medial preoptic nucleus and medial amygdala. J Neurosci. 1998;18:3967-3976.
77. Smith YR, Zubieta J-K, del Carmen MG, et al. Brain opioid receptor measurements by positron emission tomography in normal cycling women: relationship to luteinizing hormone pulsatility and gonadal steroid hormones. J Clin Endocrinol Metab. 1998;83:4498-4505.
78. Mogil JS, Marek P, OToole LA, et al. μ-Opiate receptor binding is up-regulated in mice selectively bred for high stress-induced analgesia. Brain Res. 1994;653:16-22.
79. Zubieta JK, Dannals RF, Frost JJ. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry. 1999;156:842-848.
80. Barrett AC, Cook CD, Terner JM, et al. Importance of sex and relative efficacy at the μ opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids. Psychopharmacology. 2001;158:154-164.
81. Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. PNAS. 1999;96:7723-7730.
82. Unruh AM. Gender variations in clinical pain experience. Pain. 1996;65:123-167.
83. LeResche L. Epidemiologic perspectives on sex differences in pain. In: Fillingim RB, ed. Sex, Gender, and Pain. Seattle: IASP Press; 2000:233-250.
84. Naliboff BD, Heitkemper MM, Chang L, et al. Sex and gender in irritable bowel syndrome. In: Fillingim RB, ed. Sex, Gender, and Pain. Seattle: IASP Press; 2000:327-354.
85. Aloisi AM, Albonietti ME, Carli G. Sex differences in the behavioral response to persistent pain in rats. Neurosci Lett. 1994;179:79-82.
86. Coyle DE, Sehlhorst CS, Mascari C. Female rats are more susceptible to the development of neuropathic pain using the partial sciatic nerve ligation (PSNL) model. Neurosci Lett. 1995;186:135-138.
87. Bon K, Minet-Lantéri M, Menétrey D, et al. Sex, time-of-day and estrous variations in behavioral and bladder histologic consequences of cyclophosphamide-induced cystitis in rats. Pain. 1997;73:423-429.
88. Kim SJ, Calejesan AA, Li P, et al. Sex differences in late behavioral response to subcutaneous formalin injection in mice. Brain Res. 1999;829:185-189.
89. DeLeo JA, Rutkowski MD. Gender differences in rat neuropathic pain sensitivity is dependent on strain. Neurosci Lett. 2000;282:197-199.
90. Tall JM, Stuesse SL, Cruce WLR, et al. Gender and the behavioral manifestations of neuropathic pain. Pharmacol Biochem Behav. 2001;68:99-104.
91. Schlenker EH, Martin DS, Lin XM, et al. Naloxone microinjected into the arcuate nucleus has differential effects on ventilation in male and female rats. Physio Behav. 1997;62:531-536.
92. Dahan A, Sarton E, Teppema L, et al. Sex-related differences in the influence of morphine on ventilatory control in humans. Anesthesiology. 1998;88:903-913.
93. Cruz SL, Rodríguez-Manzo G. Gender differences in the cardiovascular responses to morphine and naloxone in spinal rats. Eur J Pharmacol. 2000;397:121-128.
94. Quock RM, Vaughn LK, Barlament J, et al. Sex and strain differences in morphine-induced temperature effects in WKYs and SHRs. Brain Res Bull. 1985;14:323-326.
95. Kest B, Adler M, Hopkins E. Sex differences in thermoregulation after acute and chronic morphine administration in mice. Neurosci Lett. 2000;291:126-128.
96. 1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions. J Pharmacol Exp Ther. 1999;288:260-269.
97. Craft, RM, Ulibarri CM, Raub DJ. Kappa opioid-induced diuresis in female vs. male rats. Pharmacol Biochem Behav. 2000;65:53-59.
98. Marrazzi MA, McQuarters A, Barnes C, et al. Male/female comparison of morphine effect on food intake - relation to anorexia nervosa. Pharmacol Biochem Behav. 1996;53:433-435.
99. Stewart J, Rodaros D. The effects of gonadal hormones on the development and expression of the stimulant effects of morphine in male and female rats. Behav Brain Res. 1999;102:89-98.
100. Krzanowska EK, Bodnar RJ. Sex differences in locomotor activity following β-endorphin in the ventrolateral periaqueductal gray. Physiol Behav. 2000;68:595-598.
101. Klein LC, Popke EJ, Grunberg NE. Sex differences in effects of predictable and unpredictable footshock on fentanyl self-administration in rats. Exp Clin Psychopharm. 1997;5:99-106.
102. Lynch WJ, Carroll ME. Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats. Psychopharmacology. 1999;144:77-82.
103. Cicero TJ, Ennis T, Ogden J, et al. Gender differences in the reinforcing properties of morphine. Pharmacol Biochem Behav. 2000;65:91-96.
104. Craft RM, Stoffel EC, Stratmann JA. Effects of chronic morphine treatment on responding for intracranial stimulation in female versus male rats. Exp Clin Psychopharmacol. 2001;9:198-208.
105. Zacny JP. Morphine responses in humans: a retrospective analysis of sex differences. Drug Alcohol Depend. 2001;63:23-28.
106. Kitamura A, Kon T, Kamiyama M, et al. Menstrual stage influences postoperative nausea and vomiting following epidural buprenorphine. Acta Anesthesiol Scand. 1996;40:368-371.